Maddy summaryHR 6417 amends the existing "Ending Importation of Russian Oil Act" to ban imports of energy products (classified under Harmonized Tariff Schedule chapter 27) produced at any refinery using crude oil originating in Russia. This directly affects U.S. importers and companies bringing in such refined petroleum products. The key provision prohibits these imports regardless of where the refinery is located, targeting oil that has been "laundered" through foreign processing. The bill updates the existing law by adding this origin-based import ban as a new section.
Rep. Terri A. Sewell
Sponsored bills
Maddy summaryHR 6407, the Medical Nutrition Therapy Act of 2023, expands Medicare coverage to include medical nutrition therapy for more chronic conditions beyond current limits. It directly affects Medicare beneficiaries with conditions like obesity, hypertension, dyslipidemia, eating disorders, and others not previously covered under Part B. The bill amends Medicare rules to allow coverage for prevention, management, or treatment of these conditions by a wider range of providers, including registered dietitians and clinical psychologists. This change would make medically necessary nutrition services available for conditions listed in the bill, such as diabetes, cardiovascular disease, and HIV, as determined by the Secretary.
Maddy summaryThis bill requires Medicare to use the most recent, accurate data when calculating geographic payment adjustments for physicians, directly affecting doctors who treat Medicare patients. It specifically mandates using current physician wage data instead of non-physician wage data as a proxy, and requires updated office rent or health center expense data for practice cost calculations. The bill also establishes minimum payment floors for 2024 and beyond, preventing budget-neutral reductions in physician reimbursement rates. These changes aim to better reflect current costs for delivering care in different areas.
Maddy summaryThis bill increases tariffs on ferrosilicon imported from Russia and Belarus to 35% of the product's value, targeting ferrosilicon classified under HTS code 7202.21.50. It requires the U.S. Trade Representative to assess within 30 days whether American producers can meet domestic demand if imports decline, with a public comment period on U.S. production capacity. If U.S. producers can scale up, the bill mandates notifying Congress and considering further tariff hikes. The authority to impose these tariffs is extended through 2025.
Maddy summaryHR 5777 amends the tax code to clarify that employees using specific on-site clinic services at work are not considered covered by a health plan for health savings account (HSA) eligibility. The bill defines "qualified items and services" to include physical exams, immunizations, preventive care for chronic conditions, drug testing, and hearing/vision screenings provided at employer-operated clinics. This allows employees to access these services without losing their ability to contribute to an HSA. The change applies to taxable years beginning after the bill's enactment.
Maddy summaryThe DRA of 2023 adjusts Medicare payment rates for specific durable medical equipment (DME) items that were part of the 2021 competitive bidding program but for which no supplier contracts were finalized. It directly affects DME suppliers and Medicare beneficiaries by establishing a new 2024 payment formula: 90% of the adjusted payment amount plus 10% of the unadjusted fee schedule for eligible items. The bill also extends a temporary transition rule for non-rural areas through December 31, 2024, while delaying a regulatory change until 2025. These provisions aim to stabilize payments for DME items that did not transition to standard pricing under prior rules.
Maddy summaryThe CARE for Moms Act aims to reduce maternal mortality in the United States by improving healthcare access and quality for pregnant and postpartum women, with specific attention to racial disparities. Key provisions include requiring 12-month continuous Medicaid coverage for postpartum individuals (up from 60 days), expanding oral health coverage during pregnancy, and funding State-Based Perinatal Quality Collaboratives through $35 million annual grants. The bill specifically targets the higher maternal mortality rates faced by Black women, who are about 3 times more likely to die from pregnancy-related causes than White women. It also includes provisions for doula services, rural mobile health units, and improved data collection on maternal health outcomes.
Maddy summaryThis bill clarifies that Medicare must cover external infusion pumps and associated non-self-administrable drugs as durable medical equipment (DME) when specific criteria are met. It directly affects Medicare beneficiaries requiring home infusion therapy for drugs that must be prepared just before use, administered by a healthcare professional, or labeled for external pump use at least monthly. Key provisions require the drug's FDA labeling to specify external pump administration, safe home delivery by qualified suppliers, and preparation/administration requirements. The bill mandates Medicare coverage under existing rules (LCD L33794) for qualifying treatments, effective upon enactment or FDA approval, whichever is later.
Maddy summaryThe Preserving Access to Home Health Act of 2023 repeals a 2018 payment adjustment for Medicare home health agencies, restoring prior payment rates for 2024 and subsequent years. It requires the Medicare Payment Advisory Commission (MedPAC) to analyze how home health agencies' financial performance affects access to care, including reviewing spending and utilization data across Medicare, Medicaid, and other payers. Starting in 2025, the bill mandates home health agencies to report detailed data on visit volumes and payments by payer source (Medicare, Medicaid, private insurers) through updated cost reports. This data will help MedPAC assess payment policy impacts on access to home health services for Medicare beneficiaries.
Maddy summaryThis bill modifies tax rules for vaccines by adding new vaccines to the list of taxable vaccines under federal law. Specifically, it includes any vaccine placed on the Vaccine Injury Table under the Public Health Service Act, which determines eligibility for compensation for vaccine-related injuries. Manufacturers and distributors will need to account for these vaccines under the tax code once HHS adds them to the injury compensation list. The change affects tax reporting for these specific vaccines but does not alter vaccine access, costs, or the injury compensation program itself.